Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal" is generating significant coverage in the Business category, with 8 articles from 8 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Yahoo Finance, insights.citeline.com, Pharmaceutical Technology and Investing.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 81d ago.
Quick answers
Why is "Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease de" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- Metsera backers establish new biotech armed with China-licensed immunology asset Yahoo Finance · 84d ago
- Haisco Inks Second Deal This Year With A Startup, Worth Up To $1.5bn-Plus insights.citeline.com · 84d ago
- Metsera backers establish new biotech armed with China-licensed immunology asset Pharmaceutical Technology · 84d ago
- Haisco licenses pre-clinical drug to US venture for $1.5 billion Investing.com · 84d ago
- Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners TradingView · 84d ago
- ARCH and Population Health join China blitz with Haisco deal Endpoints News · 84d ago
- China’s Haisco forms immunology biotech with up to $1.5B from American VCs BioSpace · 84d ago
- Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal Fierce Biotech · 84d ago
Topics
Related trends
Pfizer Signs $1.5 Billion Deal With Blackstone to Fund Weight-Loss-Drug Development
Pfizer secures up to $1.5 billion from Blackstone Life Sciences to advance a once-monthly GLP-1 obesity treatment acquired from Metsera.